In the medtech and life sciences sector, trust, accuracy, and credibility are essential. Companies working in medical technology, diagnostics, digital health, and pharmaceutical development must communicate complex ideas to a diverse audience of clinicians, investors, regulators, and patients. Effec
UK based Medical Technology company Forte Medical is launching a national survey of women in the UK to ascertain their exposure to urine sampling retests and immediate empirical broad spectrum prescribing, triggered by traditional methods of specimen collection for Urinary Tract Infection and prenat
Shivani Srivastava, Marketing and Communications Lead, ChemBizR, explores the role of polymer interface materials in next-generation wearables and e-skin systems. The Forgotten Layer in Wearable Tech In the surge of innovation around wearables, biosensors, and e-skin technologies, the skin itself ha
In April 2025, NHS England delivered 2.4 million diagnostic tests – an 8.25% increase on April figures from the previous year. Yet, by the same point, 7.39 million people were still waiting for treatment. This disparity paints a stark reality: one where the UK is making progress on diagnostic capaci
Women’s cancer screening is life-saving, yet the services that support it and the workforce and technologies behind them, are facing growing pressure. Hologic brought together a Women’s Cancer Screening Taskforce of expert clinicians to examine how advanced technologies alongside workforce investmen
Dr. Cristina Richie, Lecturer in Ethics of Technology, Department of Philosophy, Edinburgh University Future’s Institute, looks at the ethical considerations raised by the environmental impact of “digital twins”. Technology has revolutionised health care. As medicine and science intersect, more heal
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, reports on a new review of the supply of continence products. NHS England is undertaking a review of the current processes and commercial mo
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, reports on a call for potential VBP pilots to be urgently identified. The UK’s Department of Health and Social Care has called for potential
After AbbVie announced the marketing authorisation from MHRA for ELAHERE, Med-Tech Insights spoke to the company to find out more. When do you anticipate mirvetuximab soravtansine will be available to eligible patients? Mirvetuximab soravtansine is now licensed as a monotherapy in the UK for the tre
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, records World Health Organization recognition for UK’s medical device regulator. The World Health Organization (WHO) has recognised the UK’s
In 1995 the FDA approved the first AI-enabled medical device, an automatic interactive gynaecological instrument to analyse Papanicolau (PAP) cervical smears. Although the FDA has been reviewing and authorising AI-enabled devices for 30 years, for most of that time these devices were a relative rari
Samuel Bateman is a senior associate and patent attorney, and Chris Froud is a partner and patent attorney, at European IP firm, Withers & Rogers. Both specialise in advising innovative companies and developers in electronics and computing. The combination of enhanced imaging technologies and AI-pow
